INVA - Innoviva, Inc.
IEX Last Trade
17.515
-0.020 -0.114%
Share volume: 12,322
Last Updated: Fri 27 Dec 2024 08:30:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$17.54
-0.02
-0.11%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-09 | 2023-02-28 | 2023-05-09 | 2023-08-02 | 2023-11-01 | 2024-02-29 | 2024-05-08 | 2024-07-31 | |
| Assets | |||||||||
| Total Assets | 1.328 B | 1.231 B | 1.130 B | 1.118 B | 1.188 B | 1.244 B | 1.268 B | 1.225 B | |
| Current Assets | 454.591 M | 443.511 M | 296.446 M | 323.538 M | 304.999 M | 344.219 M | 311.342 M | 358.277 M | |
| Inventories | 70.807 M | 55.897 M | 49.653 M | 46.846 M | 40.515 M | 40.737 M | 37.437 M | 36.664 M | |
| Other Current Assets | 75.970 M | 87.164 M | 87.254 M | 88.392 M | 73.735 M | 95.515 M | 81.409 M | 77.828 M | |
| Short Term Investments | 75.970 M | 87.164 M | 87.254 M | 88.392 M | 73.735 M | 95.515 M | 81.409 M | 77.828 M | |
| Total Receivables | 6.743 M | 9.401 M | 15.490 M | 15.275 M | 10.752 M | 14.454 M | 14.139 M | 26.782 M | |
| Current Cash | 301.071 M | 291.049 M | 144.049 M | 173.025 M | 179.997 M | 193.513 M | 178.357 M | 217.003 M | |
| Total Non-current Assets | 873.121 M | 787.986 M | 833.322 M | 794.703 M | 883.105 M | 899.288 M | 956.270 M | 866.640 M | |
| Property Plant Equipment | 165.000 K | 170.000 K | 180.000 K | 161.000 K | 361.000 K | 483.000 K | 324.000 K | 427.000 K | |
| Other Assets | 105.682 M | 101.906 M | 98.044 M | 94.257 M | 90.683 M | 87.051 M | 83.440 M | 79.854 M | |
| Intangible Assets | 258.489 M | 252.919 M | 248.314 M | 243.356 M | 236.845 M | 230.335 M | 223.895 M | 217.455 M | |
| Goodwill | 15.995 M | 26.713 M | 27.946 M | 14.882 M | 17.905 M | 17.905 M | 17.905 M | 17.905 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 1.328 B | 1.231 B | 1.130 B | 1.118 B | 1.188 B | 1.244 B | 1.268 B | 1.225 B | |
| Total liabilities | 686.344 M | 665.709 M | 568.275 M | 563.154 M | 560.611 M | 568.552 M | 563.931 M | 559.402 M | |
| Total current liabilities | 163.884 M | 134.968 M | 38.137 M | 39.398 M | 36.183 M | 38.134 M | 29.879 M | 28.206 M | |
| Accounts Payable | 3.805 M | 2.939 M | 5.933 M | 4.592 M | 3.783 M | 6.717 M | 890.000 K | 2.039 M | |
| Other liabilities | 75.718 M | 78.414 M | 77.953 M | 76.697 M | 76.757 M | 81.986 M | 82.182 M | 81.931 M | |
| Current long term debt | 96.131 M | 96.193 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 443.679 M | 444.180 M | 444.692 M | 445.201 M | 445.718 M | 446.234 M | 446.759 M | 447.282 M | |
| Other liabilities | 75.718 M | 78.414 M | 77.953 M | 76.697 M | 76.757 M | 81.986 M | 82.182 M | 81.931 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 641.368 M | 565.788 M | 561.493 M | 555.087 M | 627.493 M | 674.955 M | 703.681 M | 665.515 M | |
| Common stock | 69.731 M | 69.658 M | 67.786 M | 65.341 M | 64.953 M | 63.660 M | 63.185 M | 62.526 M | |
| Retained earnings | -136.597 M | -204.911 M | -170.046 M | -168.766 M | -86.720 M | -25.189 M | 11.343 M | -23.342 M |